Steps taken after granting the Marketing Authorisation 
For procedures finalised after 1 December 2003 please refer to module 8B 
Scope 
Application 
number 
Type of 
modification1 
Extension of shelf life as foreseen at time of authorisation. 
Extension of shelf life or retest period of the active substance. 
Changes  to  the  prefilled  syringe  plunger  stopper  (change  in  the 
sterilisation  dose  range  and  removal  of  bioburden  alert  and  limit 
levels) and to analytical methods. 
Changes  to  amend  the  Package  Leaflet  to  include  three  changes  of 
address of the local representatives. 
To  amend  sections  4.4,  4.5  and  4.8  of  the  SPC  to  introduce 
information  on  the  concurrent  use  of  anakinra  with  etanercept,  ie 
clinical  study  results  showing  increased  rate  of  serious  infections 
and neutropenia with no increase in clinical benefit 
Change(s) to the manufacturing process for the active substance 
Change(s)  to  the  test  method(s)  and/or  specifications  for  the  active 
substance 
Change(s) to the test method(s) and/or specifications for the finished 
product 
Quality changes 
Change(s) to the test method(s) and/or specifications for the finished 
product 
Change(s) to shelf-life or storage conditions 
Notification/ 
Opinion 
issued on2 
07.06.02 
08.07.02 
23.01.03 
Commission 
Decision 
Issued/amen
ded on 
11.07.02 
- 
- 
11.10.02 
23.10.02 
23.01.03 
23.04.03 
22.05.03 
I-0001 
I-0002 
II-0003 
N-0004 
II-0006 
II-0007 
I 
I 
II 
N 
II 
II 
II-0008 
II 
20.11.03 
- 
- 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended for 
procedures finalised before 01 October 2003. In accordance with Article 6 of Commission Regulation 
(EC) No 1085/2003 for procedures finalised after 01 October 2003 : I refers to a minor variation 
(Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation 
following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II 
application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) 
No 2141/96 of 7 November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 
March 1992. 
S refers to an annual reassessment. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA 
Notification date. The Commission Decision will be amended accordingly. 
1/1 
ï£©EMEA 2004 
 
 
 
 
 
 
                                                      
 
